Oxford Covid-19 vaccine produces strong immune response in older adults – trial study

November 18, 2020

Oxford covid-19 vaccine race enters crucial level three trial

The UK’s coronavirus vaccine has shown to produce a strong immune response in older adults

The UK’s coronavirus vaccine has shown to produce a strong immune response in older adults – suggesting one of the groups most vulnerable to serious illness and death from Covid-19 could build immunity. Early stage results from a study of the University of Oxford Covid-19 vaccine, published i

```

Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```